Evidence map›Paper›PMID 11120774›Full record

ArticleThe Journal of experimental medicine2000

Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2.

H Spits, F Couwenberg, A Q Bakker, K Weijer, C H Uittenbogaart

Open access · greenAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 319 citations in OpenAlex.

  1. Article
  2. Article
  3. T Cell Development: From T-Lineage Specification to Intrathymic Maturation.Advances in experimental medicine and biology · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Hearing Loss in Id1Frontiers in genetics · 2021
    Article
  11. Review
  12. Review
  13. Article
  14. Myeloid and Plasmacytoid Dendritic Cells and Cancer - New Insights.Open access Macedonian journal of medical sciences · 2019
    Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Human CD5Frontiers in immunology · 2017
    Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

H SpitsDivision of Immunology, Netherlands Cancer Institute, 10066 CX Amsterdam, The Netherlands.
F Couwenberg
A Q Bakker
K Weijer
C H Uittenbogaart
The Netherlands Cancer Institute · NL

Funding

ANALYSIS OF HIV INFECTION OF THE PEDIATRIC THYMUSR01HD029341 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI UITTENBOGAART, CHRISTEL H. · 1992 to 2000
$263k
T CELL DEVELOPMENT IN THE POSTNATAL THYMUSR21HD037597 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI UITTENBOGAART, CHRISTEL H. · 1998 to 1999
–
NICHD NIH HHS HD29341NICHD NIH HHS HD37597
6 · The paper itself

Abstract

We found previously that Id3, which inhibits transcriptional activities of many basic helix-loop-helix transcription factors, blocked T and B cell development but stimulated natural killer (NK) cell development. Here we report that ectopic expression of Id3 and another Id protein, Id2, strongly inhibited the development of primitive CD34(+)CD38(-) progenitor cells into CD123(high) dendritic cell (DC)2 precursors. In contrast, development of CD34(+)CD38(-) cells into CD4(+)CD14(+) DC1 precursors and mature DC1 was not affected by ectopic Id2 or Id3 expression. These observations support the notion of a common origin of DC2 precursors, T and B cells. As Id proteins did not block development of NK cells, a model presents itself in which these proteins drive common lymphoid precursors to develop into NK cells by inhibiting their options to develop into T cells, B cells, and pre-DC2.

Indexed as

Neoplasm ProteinsRepressor ProteinsAnimalsAntigens, CD34B-LymphocytesCell DifferentiationCell LineageCells, CulturedCoculture TechniquesDendritic CellsDNA-Binding ProteinsFlow CytometryGene Expression Regulation, DevelopmentalHematopoietic Stem CellsHumansInhibitor of Differentiation Protein 2Antigens, CD34DNA-Binding ProteinsID2 protein, humanID3 protein, humanIdb2 protein, mouseInhibitor of Differentiation Protein 2Inhibitor of Differentiation ProteinsNeoplasm ProteinsRecombinant ProteinsRepressor ProteinsTranscription Factors

Identifiers

PMID11120774
PMCPMC2213506
OpenAlexW2156498845

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.